305 related articles for article (PubMed ID: 31536851)
1. Current management of children and young people with heterozygous familial hypercholesterolaemia - HEART UK statement of care.
Ramaswami U; Humphries SE; Priestley-Barnham L; Green P; Wald DS; Capps N; Anderson M; Dale P; Morris AA
Atherosclerosis; 2019 Nov; 290():1-8. PubMed ID: 31536851
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries.
Ramaswami U; Futema M; Bogsrud MP; Holven KB; Roeters van Lennep J; Wiegman A; Descamps OS; Vrablik M; Freiberger T; Dieplinger H; Greber-Platzer S; Hanauer-Mader G; Bourbon M; Drogari E; Humphries SE
Atherosclerosis; 2020 Jan; 292():178-187. PubMed ID: 31809987
[TBL] [Abstract][Full Text] [Related]
3. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
[TBL] [Abstract][Full Text] [Related]
4. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
Nordestgaard BG; Chapman MJ; Humphries SE; Ginsberg HN; Masana L; Descamps OS; Wiklund O; Hegele RA; Raal FJ; Defesche JC; Wiegman A; Santos RD; Watts GF; Parhofer KG; Hovingh GK; Kovanen PT; Boileau C; Averna M; Borén J; Bruckert E; Catapano AL; Kuivenhoven JA; Pajukanta P; Ray K; Stalenhoef AF; Stroes E; Taskinen MR; Tybjærg-Hansen A;
Eur Heart J; 2013 Dec; 34(45):3478-90a. PubMed ID: 23956253
[TBL] [Abstract][Full Text] [Related]
5. Improving identification and management of familial hypercholesterolaemia in primary care: Pre- and post-intervention study.
Weng S; Kai J; Tranter J; Leonardi-Bee J; Qureshi N
Atherosclerosis; 2018 Jul; 274():54-60. PubMed ID: 29751285
[TBL] [Abstract][Full Text] [Related]
6. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.
Wiegman A; Gidding SS; Watts GF; Chapman MJ; Ginsberg HN; Cuchel M; Ose L; Averna M; Boileau C; Borén J; Bruckert E; Catapano AL; Defesche JC; Descamps OS; Hegele RA; Hovingh GK; Humphries SE; Kovanen PT; Kuivenhoven JA; Masana L; Nordestgaard BG; Pajukanta P; Parhofer KG; Raal FJ; Ray KK; Santos RD; Stalenhoef AF; Steinhagen-Thiessen E; Stroes ES; Taskinen MR; Tybjærg-Hansen A; Wiklund O;
Eur Heart J; 2015 Sep; 36(36):2425-37. PubMed ID: 26009596
[TBL] [Abstract][Full Text] [Related]
7. Monascus purpureus for statin and ezetimibe intolerant heterozygous familial hypercholesterolaemia patients: A clinical study.
Stefanutti C; Mazza F; Mesce D; Morozzi C; Di Giacomo S; Vitale M; Pergolini M
Atheroscler Suppl; 2017 Nov; 30():86-91. PubMed ID: 29096866
[TBL] [Abstract][Full Text] [Related]
8. The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1-year growth data.
Humphries SE; Cooper J; Dale P; Ramaswami U;
J Clin Lipidol; 2018; 12(1):25-32. PubMed ID: 29208363
[TBL] [Abstract][Full Text] [Related]
9. HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom.
France M; Rees A; Datta D; Thompson G; Capps N; Ferns G; Ramaswami U; Seed M; Neely D; Cramb R; Shoulders C; Barbir M; Pottle A; Eatough R; Martin S; Bayly G; Simpson B; Halcox J; Edwards R; Main L; Payne J; Soran H;
Atherosclerosis; 2016 Dec; 255():128-139. PubMed ID: 27839699
[TBL] [Abstract][Full Text] [Related]
10. What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?
Kayikcioglu M; Tokgozoglu L; Dogan V; Ceyhan C; Tuncez A; Kutlu M; Onrat E; Alici G; Akbulut M; Celik A; Yesilbursa D; Sahin T; Sonmez A; Ozdogan O; Temizhan A; Kilic S; Bayram F; Sabuncu T; Coskun FY; Ildizli M; Durakoglugil E; Kirilmaz B; Yilmaz MB; Yigit Z; Yildirim AB; Gedikli O; Topcu S; Oğuz A; Demir M; Yenerçağ M; Yıldırır A; Demircan S; Yilmaz M; Kaynar LG; Aktan M; Durmus RB; Gokce C; Ozcebe Oİ; Akyol TK; Okutan H; Sag S; Gul OO; Salcioglu Z; Altunkeser BB; Kuku I; Yasar HY; Kurtoglu E; Kose MD; Demircioglu S; Pekkolay Z; Ilhan O; Can LH
Atherosclerosis; 2018 Oct; 277():341-346. PubMed ID: 30270069
[TBL] [Abstract][Full Text] [Related]
11. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M; Mata P; Parhofer KG; Raal FJ; Santos RD; Sijbrands EJ; Simpson WG; Sullivan DR; Susekov AV; Tomlinson B; Wiegman A; Yamashita S; Kastelein JJ;
Eur J Prev Cardiol; 2015 Jul; 22(7):849-54. PubMed ID: 24776375
[TBL] [Abstract][Full Text] [Related]
12. The UK Paediatric Familial Hypercholesterolaemia Register: preliminary data.
Ramaswami U; Cooper J; Humphries SE;
Arch Dis Child; 2017 Mar; 102(3):255-260. PubMed ID: 26948823
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice.
Pang J; David Marais A; Blom DJ; Brice BC; Silva PR; Jannes CE; Pereira AC; Hooper AJ; Ray KK; Santos RD; Watts GF
Atherosclerosis; 2018 Oct; 277():470-476. PubMed ID: 30270087
[TBL] [Abstract][Full Text] [Related]
14. Clinical management of children and young adults with heterozygous familial hypercholesterolaemia in the UK.
Greene O; Durrington P
J R Soc Med; 2004 May; 97(5):226-9. PubMed ID: 15121812
[TBL] [Abstract][Full Text] [Related]
15. Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia.
Miltiadous G; Xenophontos S; Bairaktari E; Ganotakis M; Cariolou M; Elisaf M
Pharmacogenet Genomics; 2005 Apr; 15(4):219-25. PubMed ID: 15864114
[TBL] [Abstract][Full Text] [Related]
16. Familial Hypercholesterolemia: A Narrative Review on Diagnosis and Management Strategies for Children and Adolescents.
Tada H; Takamura M; Kawashiri MA
Vasc Health Risk Manag; 2021; 17():59-67. PubMed ID: 33628029
[TBL] [Abstract][Full Text] [Related]
17. How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment.
Farnier M; Civeira F; Descamps O;
Atheroscler Suppl; 2017 Apr; 26():25-35. PubMed ID: 28434482
[TBL] [Abstract][Full Text] [Related]
18. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
Heath KE; Gudnason V; Humphries SE; Seed M
Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
[TBL] [Abstract][Full Text] [Related]
19. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
[TBL] [Abstract][Full Text] [Related]
20. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G
Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]